Surgery Doctors in Fontana, CA Accepting Medicare

29 Surgery doctors found. Showing 21 - 29

Michael A. Shiffler, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910

Daniel David Klaristenfeld, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910

James M. Chui, MD Surgery - Plastic and Reconstructive Surgery Medicare: Medicare Enrolled Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910

Lawrence A. Harms, MD Surgery Medicare: Medicare Enrolled Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910

Dr. David Ezra Handman, M.D. Surgery - Surgical Critical Care Medicare: Accepting Medicare Assignments Practice Location: 9985 Sierra Ave, Dept Of Surgery, Fontana, CA 92335 Phone: 909-609-2008

Charlotte S. Resch, MD Surgery - Plastic and Reconstructive Surgery Medicare: Medicare Enrolled Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910

Dr. Darian Jason Behseresht, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 9985 Sierra Ave, Department Of Vascular Surgery, Fontana, CA 92335 Phone: 909-609-2008

Majid Tayyarah, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910

Ravi Veeramasuneni Kiran, MD Surgery - Surgery of the Hand Medicare: Accepting Medicare Assignments Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910

News Archive

Cancer can be found earlier in high-risk men if more aggressive screening criteria used

Men at high risk of developing prostate cancer should undergo aggressive screening for the disease. That is the recommendation following a Fox Chase Cancer Center study of 520 men at high-risk of developing prostate cancer in which 25 percent were diagnosed with the disease despite having a low PSA. The findings were presented today at the American Society of Clinical Oncology 41st Annual Meeting.

British, Austrian scientists awarded K. J. Zülch Prize for basic neurological research

British and Austrian scientists receive award for basic neurological research. Alastair Compston and Hans Lassmann are this year's recipients of the K. J. Zülch Prize for basic neurological research. In bestowing this award, the Gertrud Reemtsma Foundation is honouring two scientists who have made crucial contributions to research on multiple sclerosis. Alastair Compston's work has provided important insights into the genetics and treatment of multiple sclerosis.

Study exposes cognitive vulnerabilities to soft drink advertisements

What keeps consumers hooked on high sugar soft drink? Advertising, of course. But why are some consumers more adept at ignoring these cues than others?

Clinical trial to evaluate TAU's stem cell technology for ALS

The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University does just that, and it's now out of the lab and in hospitals to begin clinical trials with patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

Read more Medical News

› Verified 7 days ago

• 1
• 2(current)